Volume 12, Number 1Review ArticlesOpen Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US ExperienceTreatment UpdateHerbert LeporSamir S TanejaBob DjavanElisabeth EckersbergerJulia FinkelsteinHelen SadriOpen radical prostatectomy (ORP) is the reference standard for the surgical management of localized prostate cancer. With wider availability of minimally invasive radical prostatectomy techniques, there is a debate regarding the standard treatment of the management of localized prostate cancer. Therefore, we reviewed the current status of laparoscopic radical prostatectomy (LRP) and robotic-assisted laparoscopic radical prostatectomy (RALRP) as compared with ORP. Because no prospective, randomized trials comparing the different techniques have been performed, outcomes must be assessed from published series by centers that focus on ORP, LRP, and RALRP. Aside from reducing the amount of blood loss, current data suggest that the most significant outcomes (cure, continence, and potency) are no better with LRP or RALRP than with conventional ORP. Therefore, in experienced hands, ORP remains the gold standard procedure. However, there is a trend toward consistently better outcomes following RALRP in comparison with LRP. In the end, individual patient outcomes can be maximized by choosing the best modality based on the patient’s comorbid medical conditions, cancer characteristics, and surgeon experience. Future studies are needed to further investigate long-term cancer control as well as functional outcomes for RALRP series.[Rev Urol. 2010;12(1):35-43 doi: 10.3909/riu0470]Prostatic neoplasmsLaparoscopyProstatectomyRobotics
Volume 13, Number 1Case ReviewSquamous Cell Carcinoma of the ProstateCase ReviewSamir S TanejaRena D MalikGeorge DakwarMatthew E HardeeNicholas SanfilippoAndrew B Rosenkrantz"Squamous cell carcinoma of the prostate is a rare tumor, making up 0.5% to 1% of all prostate carcinomas. It is typically described as an aggressive cancer, with a median postdiagnosis survival of 14 months. Presented here is a case of primary squamous cell carcinoma of the prostate, with a complicated presentation of metastatic disease. Due to the extent of the patientís disease, he was treated with palliative radiation therapy using a four-field technique (AP/PA and left and right lateral fields) with 18 mV photons prescribed to the 100% isodose line. The prescription dose was 4000 cGy in 16 fractions of 250 cGy per fraction. No definitive treatment of squamous cell carcinoma of the prostate exists but varying approaches including surgical intervention, chemotherapy, and radiation therapy have been implemented without durable response. However, multimodal treatments appear to be the most promising with longer durations of survival. [Rev Urol. 2011;13(1):56-60 doi: 10.3909/riu0494]"Squamous cell carcinomaProstate adenocarcinomaLower urinary tractsymptomsMultimodal treatments
Volume 19, Number 3NYU Case of the MonthManagement of Prostate CancerJuly 2017Samir S Taneja[Rev Urol. 2017;19(3):180–184 doi: 10.3909/riu0771] © 2017 MedReviews®, LLC
Volume 21, Number 1NYU Case of the MonthTransperineal Saturation Prostate BiopsyNYU Case of the Month, March 2019Samir S Taneja[Rev Urol. 2019;21(1):35–40] © 2019 MedReviews®, LLC